STAT

Opinion: Microhospitals and healthplexes offer a peek at the future of health care

Smaller may trump larger when it comes to better, less expensive health care.

The once insular health care industry now finds itself facing the fallout from decades spent resisting change: an all-sides blitz orchestrated by outsiders intent on doing the changing for it. Besieged by upstarts and titans alike, even the most change-averse organizations are being forced to adapt to this threat. For leaders already laying foundations for innovation within the industry, these disruptions are providing new platforms on which to build the health care delivery models of the future.

Hospitals have long been the exemplar of the old-school model, where bigger is better, evolution is met with suspicion, and more services — regardless of their necessity — mean more lucrative kickbacks from the regulators in charge. As hospitals cling to

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About Lilly Buying A Plant, A Pfizer Antibiotic, And More
Eli Lilly agreed to acquire a manufacturing facility in Wisconsin from Nexus Pharmaceuticals to produce injectable medicines amid shortages of Mounjaro and Zepbound.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About Drug Shortages, Medicare Spending On An Alzheimer’s Drug, And More
Medicare estimates a new Alzheimer’s drug could cost the program billions of dollars by next year — well beyond what Wall Street or the drug’s manufacturer project.
STAT2 min readCrime & Violence
STAT+: Pharmalittle: We’re Reading About A Medicare Price-negotiation Ruling, Pharma’s Slipping Reputation, And More
A U.S. judge dealt a blow to two drugmakers challenging the authority for Medicare to negotiate the prices of prescription drugs.

Related Books & Audiobooks